Sort
51,593 grants matching “hepatitis”
Reducing HCV/HIV risks comparing two interventions
$548,994University Of Colorado Denver · R01 · FY2004 · DA
Molecular and Cellular Immunology
$548,991Anthony L. Defranco · University Of California, San Francisco · T32 · FY2012 · AI
Caribbean, Central and South America network for HIV epidemiology (CCASnet)
$548,969Catherine C McGowan · Vanderbilt University Medical Center · U01 · FY2015 · AI
P2 - Topical tactics to limit HIV/HSV spread by mucosal DCs
$548,949Melissa J Robbiani · Population Council · U19 · FY2008 · AI
Impact of HIV co-infections and comorbidities on circadian rhythm in the liver
$548,914Eleftherios Michailidis · Emory University · DP1 · FY2025 · DK
Investigating the Role of Hepatic Glucagon Receptor Signaling in Healthspan and Aging
$548,858Jennifer Helene Stern · University Of Arizona · R01 · FY2025 · AG
Inter-organelle communication in lipid metabolism
$548,816Bo Wang · University Of Illinois At Urbana-Champaign · R01 · FY2025 · HL
ANALYSIS OF INTRAHEPATIC MACROPHAGE PROFILES FOR PREDICTING RISK OF FIBROSIS DEVELOPMENT IN PATIENTS WITH DIFFERENT TYPES OF CHRONIC LIVER DISEASE
$548,805Heather L Stevenson · University Of Texas Med Br Galveston · R01 · FY2023 · DK
Determinants of Coronavirus Fidelity in Replication and Pathogenesis
$548,803Mark R Denison · Vanderbilt University Medical Center · R01 · FY2016 · AI
Structural Analysis of Macromolecular Assemblies
$548,743Joachim Frank · Columbia University Health Sciences · R01 · FY2012 · GM
Cr(VI) exposure and skeletal muscle differentiation and regeneration
$548,707Hong Sun · New York University School Of Medicine · R56 · FY2024 · ES
INCIDENCE OF HIV INFECTION IN A COHORT OF IV DRUG USERS
$548,692Shruti H Mehta · Johns Hopkins University · R01 · FY2007 · DA
Molecular Mechanisms of Chemoprevention: NRF2 Signaling
$548,686Thomas W Kensler · Johns Hopkins University · R01 · FY2009 · CA
Impact of CLDN1 inhibition on chemoresistance and metastasis of colon cancer
$548,542Punita Dhawan · University Of Nebraska Medical Center · R01 · FY2023 · CA
Transcriptional regulatory mechanisms in B cell development and leukemogenesis
$548,492Robert G Roeder · Rockefeller University · R01 · FY2014 · CA
Fecal microbiota transplant for Alcohol-Associated Cirrhosis
$548,474Jasmohan S Bajaj · Virginia Commonwealth University · R01 · FY2022 · AA
Examining the Impact of the Twin Epidemics of Methamphetamine and Opioid Use on Overdose, Risky Sex and Treatment Engagement among PWUD in Two Rural Appalachian Cohorts
$548,474Jennifer R Havens · University Of Kentucky · R01 · FY2024 · DA
Injectable Hydrogel Depots for Self-replicating mRNA Vaccine Delivery
$548,464James D. Bryers · University Of Washington · R01 · FY2025 · AI
Role of PERK haplotypes in HIV-Associated Neurocognitive Disorders
$548,434Kelly L Jordan-Sciutto · University Of Pennsylvania · R01 · FY2017 · MH
Promotion of fatty liver disease by the ASK1 pathway
$548,418Roger J Davis · Univ Of Massachusetts Med Sch Worcester · R01 · FY2020 · DK
Promotion of fatty liver disease by the ASK1 pathway
$548,418Roger J Davis · Univ Of Massachusetts Med Sch Worcester · R01 · FY2019 · DK
Promotion of fatty liver disease by the ASK1 pathway
$548,418Roger J Davis · Univ Of Massachusetts Med Sch Worcester · R01 · FY2021 · DK
Drug Injection Surveillance and Care Enhancement for Rural Northern New England (DISCERNNE)
$548,410Peter D. Friedmann · Baystate Medical Center, Inc. · UG3 · FY2018 · DA
Understanding human neutralizing antibodies to hepatitis C virus
$548,397Mansun Law · Scripps Research Institute, The · R01 · FY2014 · AI
Understanding human neutralizing antibodies to hepatitis C virus
$548,397Mansun Law · Scripps Research Institute, The · R01 · FY2015 · AI